Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 11 of 11 publications.

Mody FV, Goyal RK, Ajmera M, Davis KL, Amin AN. Exploring the association between heart rate control and rehospitalization: a real-world analysis of patients hospitalized with heart failure with reduced ejection fraction. Drugs Real World Outcomes. 2024 Sep;11(3):501-11. doi: 10.1007/s40801-024-00436-z

Weaver BW, Mumma JM, Parmar S, MacKay RE, Morgan JS, Ghassemian G, Gannon PR, Lee L. Understanding how infection prevention influences nurses' task sequencing using a mixed-methods, simulation-based approach. Hum Factors Health. 2023 Dec;4:100046. doi: 10.1016/j.hfh.2023.100046

Layton JB, Forns J, Turner ME, Dempsey C, Bartsch JL, Anthony MS, Danysh HE, Ritchey ME, Demos G. Falls and fractures in patients with Parkinson's Disease–related psychosis treated with Pimavanserin vs atypical antipsychotics: a cohort study. Drugs Real World Outcomes. 2022 Mar;9(1):9-22. doi: 10.1007/s40801-021-00284-1

Shah R, Girard N, Nagar SP, Griesinger F, Roeper J, Davis KL, Karimi P, Sawyer W, Yu N, Taylor A, Feliciano J. European and US real-world treatment patterns in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer: a retrospective medical record review. Drugs Real World Outcomes. 2021 Dec;8(4):537-45. doi: 10.1007/s40801-021-00261-8

Magrey M, Bozyczko M, Wolin D, Mordin M, McLeod L, Davenport E, Chirila C, Park Y. A pilot study to assess the feasibility of a web-based survey to examine patient-reported symptoms and satisfaction in patients with ankylosing spondylitis receiving secukinumab. Drugs Real World Outcomes. 2019 Jun;6(2):83-91. doi: 10.1007/S40801-019-0154-4

Kuiper JG, van Herk-Sukel MPP, Castellsague J, Pottegard A, Berglind IA, Dedman D, Gutierrez L, Calingaert B, Hallas J, Sundstrom A, Gallagher AM, Kaye JA, Pardo C, Rothman KJ, Perez-Gutthann S. Use of topical tacrolimus and topical pimecrolimus in four European countries: a multicentre database cohort study. Drugs Real World Outcomes. 2018 Jun;5(2):109-16. doi: 10.1007/s40801-018-0133-1

Krueger WS, Anthony MS, Saltus CW, Margulis AV, Rivero-Ferrer E, Monz B, Hirst C, Wormser D, Andrews E. Evaluating the safety of medication exposures during pregnancy: a case study of study designs and data sources in multiple sclerosis. Drugs Real World Outcomes. 2017 Sep;4(3):139-49. doi: 10.1007/s40801-017-0114-9

Varas-Lorenzo C, Arana A, Johannes CB, McQuay LJ, Rothman KJ, Fife D. Improving the identification of out-of-hospital sudden cardiac deaths in a general practice research database. Drugs Real World Outcomes. 2016 Sep;3(3):353-8. doi: 10.1007/s40801-016-0086-1

Parikh RC, Du XL, Morgan RO, Lairson DR. Patterns of treatment sequences in chemotherapy and targeted biologics for metastatic colorectal cancer: findings from a large community-based cohort of elderly patients. Drugs Real World Outcomes. 2016 Jan 19;1-14. doi: 10.1007/s40801-015-0059-9

Guh S, Chen XB, Poulos C, Qi Z, Cao JW, von Seidlein L, Chen JC, Wang XY, Xing ZC, Nyamete A, Clemens J, Whittington D. Comparison of cost-of-illness with willingness-to-pay estimates to avoid shigellosis: evidence from China. Health Policy Plan. 2008 Mar 1;23(2):125-36.

Canh DG, Whittington D, Thoa LTK, Utomo N, Hoa NT, Poulos C, Thuy DTD, Kim D, Nyamete A, Acosta C. Household demand for typhoid fever vaccines in Hue, Vietnam. Health Policy Plan. 2006 May 1;21(3):241-55.